Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 223 Records) |
| Query Trace: Polycythemia and JAK2[original query] |
|---|
| Triple-Negativity Identifies a Subgroup of Patients with Better Overall Survival in Essential Thrombocythemia. Hematology reports 2022 Aug 14 (3): 265-269. Santoro Marco, Accurso Vincenzo, Mancuso Salvatrice, Napolitano Mariasanta, Mattana Marta, Vajana Giorgia, Russello Federica, Siragusa Serg |
| Revisiting Diagnostic performances of serum erythropoïetin level and JAK2 mutation for polycythemias: analysis of a cohort of 1090 patients with red cell mass measurement. British journal of haematology 2021 Sep . Maslah Nabih, Ravdan Odonchimeg, Drevon Louis, Verger Emmanuelle, Belkhodja Célia, Chomienne Christine, Cassinat Bruno, Kiladjian Jean-Jacques, Giraudier Stéphane, Schlageter Marie-Hélè |
| MAPK14 over-expression is a transcriptomic feature of polycythemia vera and correlates with adverse clinical outcomes. Journal of translational medicine 2021 6 19 (1): 233. Guo Chao, Gao Ya-Yue, Ju Qian-Qian, Wang Min, Zhang Chun-Xia, Gong Ming, Li Zhen-Li |
| JAK2, CALR, and MPL Mutation Profiles in BCR-ABL Negative Myeloproliferative Neoplasms, a Referral Center Experience in the Middle East. Iranian journal of pathology 2021 5 16 (2): 190-194. Safavi Moeinadin, Monabati Ahmad, Safaei Akbar, Mirtalebi Maryam Sadat, Faghih Masoum |
| Analysis of Common Driver Mutations in Philadelphia-Negative Myeloproliferative Neoplasms. Clinical lymphoma, myeloma & leukemia 2021 4 21 (7): 483-488. Alshemmari Salem H, Rajan Reshmi, Ameen Reem, Almazyad Mazy |
| Dural Venous Sinus Thrombosis and Papilledema Related to JAK2 Mutation: A Case Series. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2021 12 1-7. Donaldson Laura, Dhoot Arjan S, Margolin Edwa |
| Clinical features and outcomes of JAK2 V617F-positive polycythemia vera and essential thrombocythemia according to the JAK2 V617F allele burden. Blood research 2021 11 56 (4): 259-265. Lee A-Jin, Kim Sang-Gyung, Nam Jun Yeb, Yun Jaehum, Ryoo Hun-Mo, Bae Sung H |
| Stiffer Spleen Predicts Higher Bone Marrow Fibrosis and Higher JAK2 Allele Burden in Patients With Myeloproliferative Neoplasms. Frontiers in oncology 2021 11 11 777730. Moia Riccardo, Cittone Micol Giulia, Boggione Paola, Manfredi Giulia Francesca, Favini Chiara, Awikeh Bassel, Pedrinelli Anita Rebecca, Mahmoud Abdurraouf Mokhtar, Nicolosi Maura, Bellan Mattia, Sainaghi Pier Paolo, Pirisi Mario, Gaidano Gianluca, Patriarca Andrea, Rigamonti Cristi |
| High Risk Janus Kinase 2 V617F Allele Burden in a Seven-Year Cohort of Patients with Myeloproliferative Neoplasms. Clinical laboratory 2021 11 67 (11): . Chatambudza Moses, Skhosana Lindiwe, Ketseoglou Irene, Wiggill Trac |
| JAK2 p.(V617F) mutation in Tunisian myeloproliferative neoplasms and its genotype-phenotype correlation. The Pan African medical journal 2021 39 194. Sassi Hela, Menif Samia, Ammar Safa Ben, Farrah Ahlem, Othmen Hend Ben Hadj, Amouri Hassi |
| JAK2 and TET2 Mutation in Polycythemia Vera. Cureus 2021 10 13 (9): e17854. Padda Jaskamal, Khalid Khizer, Yadav Jayant, Almanie Abdulelah H, Mehta Krutagni Adwait, Al Hennawi Hussam, Boddeti Nymisha L, Campos Victor Yosef Melt, Jean-Charles Gutterid |
| [Clinical Characteristics of Patients with JAK2 Gene Mutation Myeloproliferative Neoplasms]. Zhongguo shi yan xue ye xue za zhi 2021 10 29 (5): 1533-1539. Li Yu-Jin, Zhu Shi-Rong, Liu Wei-Yi, Ming Jing, Wang Zi-Qing, Zhang Shan-Shan, Hu Xiao-M |
| Characteristics of patients with cerebral sinus venous thrombosis and JAK2 V617F mutation. Acta neurologica Belgica 2022 Sep . Simaan Naaem, Molad Jeremy, Honig Asaf, Filioglo Andrei, Shbat Fadi, Auriel Eitan, Barnea Rani, Hallevi Hen, Seyman Estelle, Mendel Rom, Leker Ronen R, Peretz Shlo |
| von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well-controlled platelet counts. European journal of haematology 2022 9 109 (6): 779-786. Iizuka Kazuhide, Morishita Soji, Nishizaki Yuji, Iizuka Yoshikazu, Iriyama Noriyoshi, Ochiai Tomonori, Yanagisawa Naotake, Yasuda Hajime, Ando Jun, Gotoh Akihiko, Takei Masami, Hatta Yoshihiro, Nakamura Hideki, Nakayama Tomohiro, Komatsu Nor |
| The prevalence of JAK2 exon12 mutations in Vietnamese patients with JAK2 V617F-negative polycythemia vera: frequent or rare? Human heredity 2022 Aug . Nguyen Ngoc T, Nguyen Linh T, Nguyen Xuan |
| JAK2 rs10974944 is associated with both V617F-positive and negative myeloproliferative neoplasms in a Vietnamese population: A potential genetic marker. Molecular genetics & genomic medicine 2022 Aug e2044. Ngoc Nguyen Thy, Hau Bui Bich, Vuong Nguyen Ba, Xuan Nguyen T |
| The differences of hemogram, myelogram, and driver gene mutations in classic myeloproliferative neoplasms. Blood cells, molecules & diseases 2022 8 97 102698. Wang Jin, Zhang Jin, Huang Jinjin, Mei Yu, Hong Zhen |
| Clinical characteristics of Japanese patients with polycythemia vera: results of the JSH-MPN-R18 study. International journal of hematology 2022 7 116 (5): 696-711. Edahiro Yoko, Ito Tomoki, Gotoh Akihiko, Nakamae Mika, Kimura Fumihiko, Koike Michiaki, Kirito Keita, Wada Hideho, Usuki Kensuke, Tanaka Takayuki, Mori Takehiko, Wakita Satoshi, Saito Toshiki I, Kada Akiko, Saito Akiko M, Shimoda Kazuya, Sugimoto Yuka, Kurokawa Toshiro, Tomita Akihiro, Hashimoto Yoshinori, Akashi Koichi, Matsumura Itaru, Takenaka Katsuto, Komatsu Nor |
| Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients. Cancer medicine 2022 7 12 (2): 1079-1089. Mori Yosuke, Araki Marito, Morishita Soji, Imai Misa, Edahiro Yoko, Ito Masafumi, Ochiai Tomonori, Shirane Shuichi, Hashimoto Yoshinori, Yasuda Hajime, Ando Jun, Ando Miki, Komatsu Nor |
| Clinical features associated with thrombotic events in children with myeloproliferative neoplasms. American journal of hematology 2022 6 97 (9): E353-E355. Shimano Kristin A, Vanderpoel Victoria, Stone Hannah, Resar Linda, Kucine Nico |
| TET2, DNMT3A, IDH1, and JAK2 Mutation in Myeloproliferative Neoplasms in southern Iran. International journal of organ transplantation medicine 2022 5 12 (3): 12-20. Abedi E, Ramzi M, Karimi M, Yaghobi R, Mohammadi H, Bayat E, Moghadam M, Farokhian F, Dehghani M, Golafshan H A, Haghpanah |
| [Clinical and laboratory features compared between JAK2 exon12 and JAK2 V617F mutated polycythemia vera]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2022 4 43 (2): 107-114. Liu D, Zhang P H, Xu Z F, Ma J, Qin T J, Qu S Q, Sun X J, Li B, Pan L J, Jia Y J, Xiao Z |
| Lab tests for MPN. International review of cell and molecular biology 2022 2 366 187-220. Moncada Alice, Pancrazzi Alessand |
| Novel JAK2 Exon 14 Mutations L611S or N622Y in cis with JAK2V617F Are Associated with Distinct Clinical Phenotype of Polycythemia Vera and Concurrent Eosinophilia. Acta haematologica 2022 11 146 (1): 76-81. Patel Ameet, Juskevicius Ridas, Mohan Sanj |
| JAK2V617F variant allele frequency, non-driver mutations, single-nucleotide variants and polycythemia vera outcome. Journal of cancer research and clinical oncology 2022 Oct . Kandu?a Zuzanna, Janowski Micha?, Wi?ckowska Barbara, Paczkowska Edyta, Lewandowski Krzyszt |
| Allelic burden of Janus kinase 2 in a 6-month course of therapy for myeloproliferative neoplasms. Molecular biology reports 2023 5 . It?r ?irino?lu Demiriz, Mehmet Hanifi Kazanci, Esra Menfaatli, Davoud Jafari-Gharabaghlou, Nosratollah Zargha |
| Increase in Frequency of Myeloid-Derived Suppressor Cells in the Bone Marrow of Myeloproliferative Neoplasm: Potential Implications in Myelofibrosis. Advances in experimental medicine and biology 2023 4 1408 273-290. Sun?ica Kapor, Sanja Mom?ilovi?, Slobodan Kapor, Slavko Mojsilovi?, Milica Radojkovi?, Milica Apostolovi?, Branka Filipovi?, Mirjana Goti?, Vladan ?oki?, Juan F Santiban |
| Iron homeostasis governs erythroid phenotype in Polycythemia Vera. Blood 2023 3 . Bennett Cavan, Jackson Victoria E, Pettikiriarachchi Anne, Hayman Thomas, Schaeper Ute, Moir-Meyer Gemma L, Fielding Katherine Louise, Ataide Ricardo, Clucas Danielle, Baldi Andrew James, Garnham Alexandra L, Li-Wai-Suen Connie Sn, Loughran Stephen John, Baxter E Joanna, Green Anthony R, Alexander Warren S, Bahlo Melanie, Burbury Kate, Ng Ashley P, Pasricha Sant-Ra |
| Genetic and Clinical Characteristics of Patients with Philadelphia-Negative Myeloproliferative Neoplasm Carrying Concurrent Mutations in JAK2V617F, CALR, and MPL. Technology in cancer research & treatment 2023 2 22 15330338231154092. Wang Yan, Ran Fei, Lin Jin, Zhang Jing, Ma D |
| The Impact of JAK2 V617F, CALR, and MPL Mutations as Molecular Diagnostic Markers of Myeloproliferative Neoplasms in Kurdish Patients. A Single-center Experience. Cellular and molecular biology (Noisy-le-Grand, France) 2023 2 68 (8): 202-209. Basim Najm Maysam, Jalal Sana Dlawar, Getta Hisham Ar |
- Page last reviewed:Feb 1, 2023
- Page last updated:Jun 02, 2023
- Content source: